XT
NXTC icon

XTX Topco’s NextCure NXTC Stock Holding History

XTX Topco’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,502
Closed -$8.66K – 2932
2025
Q1 		$8.66K Buy
1,502
+371
+33% +$3.27K ﹤0.01% 2266
2024
Q4 		$10.5K Buy
+1,131
New +$16.6K ﹤0.01% 2142
2024
Q3 		– Sell
-1,740
Closed -$33.2K – 2448
2024
Q2 		$33.2K Buy
1,740
+100
+6% +$1.95K ﹤0.01% 1552
2024
Q1 		$43.9K Buy
1,640
+204
+14% +$3.51K 0.01% 1490
2023
Q4 		$19.6K Buy
+1,436
New +$20.8K ﹤0.01% 1361
2022
Q3 		– Sell
-1,827
Closed -$103K – 1301
2022
Q2 		$103K Buy
+1,827
New +$95.4K 0.04% 637

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return

XTX Topco's NXTC Position: Q2 2025 in Review

XTX Topco sold out of NextCure (NXTC) in Q2 2025, closing a stake of 1,502 shares — an estimated $8.66K sold.

XTX Topco first reported a position in NXTC in Q2 2022 and held it in 6 quarters. The position peaked at $103K in Q2 2022. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2025.

  • XTX Topco reported no remaining NextCure position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 1,502 NextCure shares in Q2 2025, an estimated $8.66K.
  • XTX Topco first reported a position in NextCure in Q2 2022 and held it in 6 quarters.
  • XTX Topco's NextCure position peaked at $103K in Q2 2022.
  • 30 funds tracked by Wall St. Rank held NextCure as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.